Table of Contents  

An update on the pathogenesis of type 2 diabetes mellitus

Sabine Kahl, Michael Roden
Published in : HAMDAN MEDICAL JOURNAL ; Vol 5, No 2 (2012)
DOI : 10.7707/hmj.v5i2.167

Abstract


The most common form of diabetes mellitus, type 2 diabetes mellitus (T2DM), is characterized by impaired insulin sensitivity of skeletal muscle, liver and adipose tissue, termed insulin resistance (IR), and by inadequate insulin secretion by pancreatic β cells, termed β-cell dysfunction. Recent studies propose that the brain may also contribute to IR and to the pathogenesis of T2DM. There is growing evidence that IR is the earliest detectable abnormality, whereas β-cell exhaustion is mandatory for manifesting overt T2DM. The current concepts of possible mechanisms underlying IR are lipid overflow (lipotoxicity), abnormal energy balance and mitochondrial function, subclinical inflammation, and central neuronal mechanisms. Here we review the relative roles of these mechanisms for the development of T2DM.

 


View article in  :   PDF     HTML    

References


References

Nolan,CJ, Damm,P, Prentki,M: Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 378:169-181, 2011

Bressler,P, Bailey,SR, Matsuda,M, DeFronzo,RA: Insulin resistance and coronary artery disease. Diabetologia 39:1345-1350, 1996

Inzucchi,SE, Bergenstal,RM, Buse,JB, Diamant,M, Ferrannini,E, Nauck,M, Peters,AL, Tsapas,A, Wender,R, Matthews,DR: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 55:1577-1596, 2012

Tabak,AG, Brunner,EJ, Miller,MA, Karanam,S, McTernan,PG, Cappuccio,FP, Witte,DR: Low serum adiponectin predicts 10-year risk of type 2 diabetes and HbA1c independently of obesity, lipids, and inflammation: Whitehall II study. Horm Metab Res 41:626-629, 2009

DeFronzo,RA: Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58:773-795, 2009

Standards of medical care in diabetes--2012. Diabetes Care 35 Suppl 1:S11-S63, 2012

Katz,LD, Glickman,MG, Rapoport,S, Ferrannini,E, DeFronzo,RA: Splanchnic and peripheral disposal of oral glucose in man. Diabetes 32:675-679, 1983

Mari,A, Wahren,J, DeFronzo,RA, Ferrannini,E: Glucose absorption and production following oral glucose: comparison of compartmental and arteriovenous-difference methods. Metabolism 43:1419-1425, 1994

Roden M. Clinical Diabetes Research: Methods and Techniques. 2007. John Wiley & Sons.

Abdul-Ghani,MA, DeFronzo,RA: Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol 2010:476279, 2010

Perseghin,G, Ghosh,S, Gerow,K, Shulman,GI: Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes 46:1001-1009, 1997

Danadian,K, Balasekaran,G, Lewy,V, Meza,MP, Robertson,R, Arslanian,SA: Insulin sensitivity in African-American children with and without family history of type 2 diabetes. Diabetes Care 22:1325-1329, 1999

Petersen,KF, Dufour,S, Befroy,D, Garcia,R, Shulman,GI: Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664-671, 2004

Davis,CL, Gutt,M, Llabre,MM, Marks,JB, O'Sullivan,MJ, Potter,JE, Landel,JL, Kumar,M, Schneiderman,N, Gellman,M, Skyler,JS: History of gestational diabetes, insulin resistance and coronary risk. J Diabetes Complications 13:216-223, 1999

Bonadonna,RC, Groop,L, Kraemer,N, Ferrannini,E, Del,PS, DeFronzo,RA: Obesity and insulin resistance in humans: a dose-response study. Metabolism 39:452-459, 1990

Karelis,AD, Faraj,M, Bastard,JP, St-Pierre,DH, Brochu,M, Prud'homme,D, Rabasa-Lhoret,R: The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 90:4145-4150, 2005

Roden,M: Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes. Int J Obes (Lond) 29 Suppl 2:S111-S115, 2005

Shulman,GI, Rothman,DL, Jue,T, Stein,P, DeFronzo,RA, Shulman,RG: Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223-228, 1990

Rothman,DL, Shulman,RG, Shulman,GI: 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest 89:1069-1075, 1992

Cline,GW, Petersen,KF, Krssak,M, Shen,J, Hundal,RS, Trajanoski,Z, Inzucchi,S, Dresner,A, Rothman,DL, Shulman,GI: Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341:240-246, 1999

Szendroedi,J, Schmid,AI, Chmelik,M, Toth,C, Brehm,A, Krssak,M, Nowotny,P, Wolzt,M, Waldhausl,W, Roden,M: Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. PLoS Med 4:e154, 2007

Savage,DB, Zhai,L, Ravikumar,B, Choi,CS, Snaar,JE, McGuire,AC, Wou,SE, Medina-Gomez,G, Kim,S, Bock,CB, Segvich,DM, Solanky,B, Deelchand,D, Vidal-Puig,A, Wareham,NJ, Shulman,GI, Karpe,F, Taylor,R, Pederson,BA, Roach,PJ, O'Rahilly,S, DePaoli-Roach,AA: A prevalent variant in PPP1R3A impairs glycogen synthesis and reduces muscle glycogen content in humans and mice. PLoS Med 5:e27, 2008

Rothman,DL, Magnusson,I, Cline,G, Gerard,D, Kahn,CR, Shulman,RG, Shulman,GI: Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 92:983-987, 1995

Kacerovsky-Bielesz,G, Chmelik,M, Ling,C, Pokan,R, Szendroedi,J, Farukuoye,M, Kacerovsky,M, Schmid,AI, Gruber,S, Wolzt,M, Moser,E, Pacini,G, Smekal,G, Groop,L, Roden,M: Short-term exercise training does not stimulate skeletal muscle ATP synthesis in relatives of humans with type 2 diabetes. Diabetes 58:1333-1341, 2009

Kacerovsky-Bielesz,G, Kacerovsky,M, Chmelik,M, Farukuoye,M, Ling,C, Pokan,R, Tschan,H, Szendroedi,J, Schmid,AI, Gruber,S, Herder,C, Wolzt,M, Moser,E, Pacini,G, Smekal,G, Groop,L, Roden,M: A single nucleotide polymorphism associates with the response of muscle ATP synthesis to long-term exercise training in relatives of type 2 diabetic humans. Diabetes Care 35:350-357, 2012

Bogan,JS: Regulation of Glucose Transporter Translocation in Health and Diabetes. Annu Rev Biochem 2012

Ciaraldi,TP, Abrams,L, Nikoulina,S, Mudaliar,S, Henry,RR: Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 96:2820-2827, 1995

Garvey,WT, Maianu,L, Zhu,JH, Brechtel-Hook,G, Wallace,P, Baron,AD: Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 101:2377-2386, 1998

Zierath,JR, He,L, Guma,A, Odegoard,WE, Klip,A, Wallberg-Henriksson,H: Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM. Diabetologia 39:1180-1189, 1996

Leng,Y, Karlsson,HK, Zierath,JR: Insulin signaling defects in type 2 diabetes. Rev Endocr Metab Disord 5:111-117, 2004

Karlsson,HK, Zierath,JR, Kane,S, Krook,A, Lienhard,GE, Wallberg-Henriksson,H: Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. Diabetes 54:1692-1697, 2005

Karlsson,HK, Ahlsen,M, Zierath,JR, Wallberg-Henriksson,H, Koistinen,HA: Insulin signaling and glucose transport in skeletal muscle from first-degree relatives of type 2 diabetic patients. Diabetes 55:1283-1288, 2006

Luan,B, Zhao,J, Wu,H, Duan,B, Shu,G, Wang,X, Li,D, Jia,W, Kang,J, Pei,G: Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance. Nature 457:1146-1149, 2009

Chiu,TT, Jensen,TE, Sylow,L, Richter,EA, Klip,A: Rac1 signalling towards GLUT4/glucose uptake in skeletal muscle. Cell Signal 23:1546-1554, 2011

JeBailey,L, Wanono,O, Niu,W, Roessler,J, Rudich,A, Klip,A: Ceramide- and oxidant-induced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells. Diabetes 56:394-403, 2007

Bostrom,P, Andersson,L, Vind,B, Haversen,L, Rutberg,M, Wickstrom,Y, Larsson,E, Jansson,PA, Svensson,MK, Branemark,R, Ling,C, Beck-Nielsen,H, Boren,J, Hojlund,K, Olofsson,SO: The SNARE protein SNAP23 and the SNARE-interacting protein Munc18c in human skeletal muscle are implicated in insulin resistance/type 2 diabetes. Diabetes 59:1870-1878, 2010

Vassilopoulos,S, Esk,C, Hoshino,S, Funke,BH, Chen,CY, Plocik,AM, Wright,WE, Kucherlapati,R, Brodsky,FM: A role for the CHC22 clathrin heavy-chain isoform in human glucose metabolism. Science 324:1192-1196, 2009

Szendroedi,J, Phielix,E, Roden,M: The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol 8:92-103, 2012

Schrauwen-Hinderling,VB, Kooi,ME, Hesselink,MK, Jeneson,JA, Backes,WH, van Echteld,CJ, van Engelshoven,JM, Mensink,M, Schrauwen,P: Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 50:113-120, 2007

Phielix,E, Schrauwen-Hinderling,VB, Mensink,M, Lenaers,E, Meex,R, Hoeks,J, Kooi,ME, Moonen-Kornips,E, Sels,JP, Hesselink,MK, Schrauwen,P: Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients. Diabetes 57:2943-2949, 2008

Petersen,KF, Dufour,S, Shulman,GI: Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLoS Med 2:e233, 2005

Petersen,KF, Befroy,D, Dufour,S, Dziura,J, Ariyan,C, Rothman,DL, DiPietro,L, Cline,GW, Shulman,GI: Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140-1142, 2003

Brehm,A, Krssak,M, Schmid,AI, Nowotny,P, Waldhausl,W, Roden,M: Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes 55:136-140, 2006

Abdul-Ghani,MA, Jani,R, Chavez,A, Molina-Carrion,M, Tripathy,D, DeFronzo,RA: Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants. Diabetologia 52:574-582, 2009

Rabol,R, Boushel,R, Dela,F: Mitochondrial oxidative function and type 2 diabetes. Appl Physiol Nutr Metab 31:675-683, 2006

Chomentowski,P, Coen,PM, Radikova,Z, Goodpaster,BH, Toledo,FG: Skeletal muscle mitochondria in insulin resistance: differences in intermyofibrillar versus subsarcolemmal subpopulations and relationship to metabolic flexibility. J Clin Endocrinol Metab 96:494-503, 2011

Morino,K, Petersen,KF, Dufour,S, Befroy,D, Frattini,J, Shatzkes,N, Neschen,S, White,MF, Bilz,S, Sono,S, Pypaert,M, Shulman,GI: Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest 115:3587-3593, 2005

Benton,CR, Holloway,GP, Han,XX, Yoshida,Y, Snook,LA, Lally,J, Glatz,JF, Luiken,JJ, Chabowski,A, Bonen,A: Increased levels of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1alpha) improve lipid utilisation, insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats. Diabetologia 53:2008-2019, 2010

Patti,ME, Butte,AJ, Crunkhorn,S, Cusi,K, Berria,R, Kashyap,S, Miyazaki,Y, Kohane,I, Costello,M, Saccone,R, Landaker,EJ, Goldfine,AB, Mun,E, DeFronzo,R, Finlayson,J, Kahn,CR, Mandarino,LJ: Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100:8466-8471, 2003

Mootha,VK, Lindgren,CM, Eriksson,KF, Subramanian,A, Sihag,S, Lehar,J, Puigserver,P, Carlsson,E, Ridderstrale,M, Laurila,E, Houstis,N, Daly,MJ, Patterson,N, Mesirov,JP, Golub,TR, Tamayo,P, Spiegelman,B, Lander,ES, Hirschhorn,JN, Altshuler,D, Groop,LC: PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267-273, 2003

Koves,TR, Li,P, An,J, Akimoto,T, Slentz,D, Ilkayeva,O, Dohm,GL, Yan,Z, Newgard,CB, Muoio,DM: Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem 280:33588-33598, 2005

Michael,LF, Wu,Z, Cheatham,RB, Puigserver,P, Adelmant,G, Lehman,JJ, Kelly,DP, Spiegelman,BM: Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1. Proc Natl Acad Sci U S A 98:3820-3825, 2001

Bonen,A: PGC-1alpha-induced improvements in skeletal muscle metabolism and insulin sensitivity. Appl Physiol Nutr Metab 34:307-314, 2009

Szendroedi,J, Roden,M: Ectopic lipids and organ function. Curr Opin Lipidol 20:50-56, 2009

Machann,J, Haring,H, Schick,F, Stumvoll,M: Intramyocellular lipids and insulin resistance. Diabetes Obes Metab 6:239-248, 2004

Anderwald,C, Bernroider,E, Krssak,M, Stingl,H, Brehm,A, Bischof,MG, Nowotny,P, Roden,M, Waldhausl,W: Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle. Diabetes 51:3025-3032, 2002

Kautzky-Willer,A, Krssak,M, Winzer,C, Pacini,G, Tura,A, Farhan,S, Wagner,O, Brabant,G, Horn,R, Stingl,H, Schneider,B, Waldhausl,W, Roden,M: Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes 52:244-251, 2003

Perseghin,G, Scifo,P, Danna,M, Battezzati,A, Benedini,S, Meneghini,E, Del,MA, Luzi,L: Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation. Am J Physiol Endocrinol Metab 283:E556-E564, 2002

Samuel,VT, Petersen,KF, Shulman,GI: Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375:2267-2277, 2010

Brehm,A, Krssak,M, Schmid,AI, Nowotny,P, Waldhausl,W, Roden,M: Acute elevation of plasma lipids does not affect ATP synthesis in human skeletal muscle. Am J Physiol Endocrinol Metab 299:E33-E38, 2010

Bikman,BT, Summers,SA: Ceramides as modulators of cellular and whole-body metabolism. J Clin Invest 121:4222-4230, 2011

Griffin,ME, Marcucci,MJ, Cline,GW, Bell,K, Barucci,N, Lee,D, Goodyear,LJ, Kraegen,EW, White,MF, Shulman,GI: Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48:1270-1274, 1999

Yu,C, Chen,Y, Cline,GW, Zhang,D, Zong,H, Wang,Y, Bergeron,R, Kim,JK, Cushman,SW, Cooney,GJ, Atcheson,B, White,MF, Kraegen,EW, Shulman,GI: Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277:50230-50236, 2002

Kim,JK, Fillmore,JJ, Sunshine,MJ, Albrecht,B, Higashimori,T, Kim,DW, Liu,ZX, Soos,TJ, Cline,GW, O'Brien,WR, Littman,DR, Shulman,GI: PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest 114:823-827, 2004

Morino,K, Neschen,S, Bilz,S, Sono,S, Tsirigotis,D, Reznick,RM, Moore,I, Nagai,Y, Samuel,V, Sebastian,D, White,M, Philbrick,W, Shulman,GI: Muscle-specific IRS-1 Ser->Ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle. Diabetes 57:2644-2651, 2008

Itani,SI, Pories,WJ, Macdonald,KG, Dohm,GL: Increased protein kinase C theta in skeletal muscle of diabetic patients. Metabolism 50:553-557, 2001

Itani,SI, Ruderman,NB, Schmieder,F, Boden,G: Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51:2005-2011, 2002

Hoeg,LD, Sjoberg,KA, Jeppesen,J, Jensen,TE, Frosig,C, Birk,JB, Bisiani,B, Hiscock,N, Pilegaard,H, Wojtaszewski,JF, Richter,EA, Kiens,B: Lipid-induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signaling. Diabetes 60:64-73, 2011

Chavez,JA, Knotts,TA, Wang,LP, Li,G, Dobrowsky,RT, Florant,GL, Summers,SA: A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278:10297-10303, 2003

Zhou,H, Summers,SA, Birnbaum,MJ, Pittman,RN: Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J Biol Chem 273:16568-16575, 1998

Blachnio-Zabielska,A, Baranowski,M, Zabielski,P, Gorski,J: Effect of high fat diet enriched with unsaturated and diet rich in saturated fatty acids on sphingolipid metabolism in rat skeletal muscle. J Cell Physiol 225:786-791, 2010

Holland,WL, Bikman,BT, Wang,LP, Yuguang,G, Sargent,KM, Bulchand,S, Knotts,TA, Shui,G, Clegg,DJ, Wenk,MR, Pagliassotti,MJ, Scherer,PE, Summers,SA: Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest 121:1858-1870, 2011

Liberman,Z, Eldar-Finkelman,H: Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling. J Biol Chem 280:4422-4428, 2005

Dokken,BB, Sloniger,JA, Henriksen,EJ: Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle. Am J Physiol Endocrinol Metab 288:E1188-E1194, 2005

Henriksen,EJ, Teachey,MK: Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats. Metabolism 56:931-938, 2007

Henriksen,EJ, Teachey,MK, Lindborg,KA, Diehl,CJ, Beneze,AN: The high-fat-fed lean Zucker rat: a spontaneous isocaloric model of fat-induced insulin resistance associated with muscle GSK-3 overactivity. Am J Physiol Regul Integr Comp Physiol 294:R1813-R1821, 2008

Hommelberg,PP, Langen,RC, Schols,AM, Mensink,RP, Plat,J: Inflammatory signaling in skeletal muscle insulin resistance: green signal for nutritional intervention? Curr Opin Clin Nutr Metab Care 13:647-655, 2010

Gao,Z, Wang,Z, Zhang,X, Butler,AA, Zuberi,A, Gawronska-Kozak,B, Lefevre,M, York,D, Ravussin,E, Berthoud,HR, McGuinness,O, Cefalu,WT, Ye,J: Inactivation of PKCtheta leads to increased susceptibility to obesity and dietary insulin resistance in mice. Am J Physiol Endocrinol Metab 292:E84-E91, 2007

Sun,Z, Arendt,CW, Ellmeier,W, Schaeffer,EM, Sunshine,MJ, Gandhi,L, Annes,J, Petrzilka,D, Kupfer,A, Schwartzberg,PL, Littman,DR: PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 404:402-407, 2000

Shi,H, Kokoeva,MV, Inouye,K, Tzameli,I, Yin,H, Flier,JS: TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-3025, 2006

Radin,MS, Sinha,S, Bhatt,BA, Dedousis,N, O'Doherty,RM: Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Diabetologia 51:336-346, 2008

Tsukumo,DM, Carvalho-Filho,MA, Carvalheira,JB, Prada,PO, Hirabara,SM, Schenka,AA, Araujo,EP, Vassallo,J, Curi,R, Velloso,LA, Saad,MJ: Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56:1986-1998, 2007

Senn,JJ: Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J Biol Chem 281:26865-26875, 2006

Dietze,D, Koenen,M, Rohrig,K, Horikoshi,H, Hauner,H, Eckel,J: Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. Diabetes 51:2369-2376, 2002

Lumeng,CN, Bodzin,JL, Saltiel,AR: Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117:175-184, 2007

Varma,V, Yao-Borengasser,A, Rasouli,N, Nolen,GT, Phanavanh,B, Starks,T, Gurley,C, Simpson,P, McGehee,RE, Jr., Kern,PA, Peterson,CA: Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am J Physiol Endocrinol Metab 296:E1300-E1310, 2009

Barazzoni,R, Zanetti,M, Cappellari,GG, Semolic,A, Boschelle,M, Codarin,E, Pirulli,A, Cattin,L, Guarnieri,G: Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-kappaB inhibitor (IkappaB)-nuclear factor-kappaB (NFkappaB) activation in rat muscle, in the absence of mitochondrial dysfunction. Diabetologia 55:773-782, 2012

Roberts,CK, Barnard,RJ, Sindhu,RK, Jurczak,M, Ehdaie,A, Vaziri,ND: Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism 55:928-934, 2006

Osborn,O, Olefsky,JM: The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 18:363-374, 2012

Hotamisligil,GS: Inflammation and endoplasmic reticulum stress in obesity and diabetes. Int J Obes (Lond) 32 Suppl 7:S52-S54, 2008

Ozcan,U, Cao,Q, Yilmaz,E, Lee,AH, Iwakoshi,NN, Ozdelen,E, Tuncman,G, Gorgun,C, Glimcher,LH, Hotamisligil,GS: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306:457-461, 2004

Jiao,P, Ma,J, Feng,B, Zhang,H, Diehl,JA, Chin,YE, Yan,W, Xu,H: FFA-induced adipocyte inflammation and insulin resistance: involvement of ER stress and IKKbeta pathways. Obesity (Silver Spring) 19:483-491, 2011

Lee,YY, Hong,SH, Lee,YJ, Chung,SS, Jung,HS, Park,SG, Park,KS: Tauroursodeoxycholate (TUDCA), chemical chaperone, enhances function of islets by reducing ER stress. Biochem Biophys Res Commun 397:735-739, 2010

Litherland,GJ, Hajduch,E, Hundal,HS: Intracellular signalling mechanisms regulating glucose transport in insulin-sensitive tissues (review). Mol Membr Biol 18:195-204, 2001

Hage,HR, Hainault,I, Vilquin,JT, Samama,C, Lasnier,F, Ferre,P, Foufelle,F, Hajduch,E: Endoplasmic reticulum stress does not mediate palmitate-induced insulin resistance in mouse and human muscle cells. Diabetologia 55:204-214, 2012

Boden,G, Cheung,P, Stein,TP, Kresge,K, Mozzoli,M: FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. Am J Physiol Endocrinol Metab 283:E12-E19, 2002

Gastaldelli,A, Cusi,K, Pettiti,M, Hardies,J, Miyazaki,Y, Berria,R, Buzzigoli,E, Sironi,AM, Cersosimo,E, Ferrannini,E, DeFronzo,RA: Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 133:496-506, 2007

Roden,M, Bernroider,E: Hepatic glucose metabolism in humans--its role in health and disease. Best Pract Res Clin Endocrinol Metab 17:365-383, 2003

Basu,R, Chandramouli,V, Dicke,B, Landau,B, Rizza,R: Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes 54:1942-1948, 2005

Basu,R, Schwenk,WF, Rizza,RA: Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes. Am J Physiol Endocrinol Metab 287:E55-E62, 2004

Krssak,M, Brehm,A, Bernroider,E, Anderwald,C, Nowotny,P, Dalla,MC, Cobelli,C, Cline,GW, Shulman,GI, Waldhausl,W, Roden,M: Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes. Diabetes 53:3048-3056, 2004

Gastaldelli,A, Toschi,E, Pettiti,M, Frascerra,S, Quinones-Galvan,A, Sironi,AM, Natali,A, Ferrannini,E: Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. Diabetes 50:1807-1812, 2001

Wajngot,A, Chandramouli,V, Schumann,WC, Ekberg,K, Jones,PK, Efendic,S, Landau,BR: Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus. Metabolism 50:47-52, 2001

Rothman,DL, Magnusson,I, Katz,LD, Shulman,RG, Shulman,GI: Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science 254:573-576, 1991

Gastaldelli,A, Baldi,S, Pettiti,M, Toschi,E, Camastra,S, Natali,A, Landau,BR, Ferrannini,E: Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 49:1367-1373, 2000

Nielsen,MF, Nyholm,B, Caumo,A, Chandramouli,V, Schumann,WC, Cobelli,C, Landau,BR, Rizza,RA, Schmitz,O: Prandial glucose effectiveness and fasting gluconeogenesis in insulin-resistant first-degree relatives of patients with type 2 diabetes. Diabetes 49:2135-2141, 2000

Tomiyasu,M, Obata,T, Nishi,Y, Nakamoto,H, Nonaka,H, Takayama,Y, Autio,J, Ikehira,H, Kanno,I: Monitoring of liver glycogen synthesis in diabetic patients using carbon-13 MR spectroscopy. Eur J Radiol 73:300-304, 2010

Petersen,KF, Dufour,S, Savage,DB, Bilz,S, Solomon,G, Yonemitsu,S, Cline,GW, Befroy,D, Zemany,L, Kahn,BB, Papademetris,X, Rothman,DL, Shulman,GI: The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc Natl Acad Sci U S A 104:12587-12594, 2007

Dong,XC, Copps,KD, Guo,S, Li,Y, Kollipara,R, DePinho,RA, White,MF: Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab 8:65-76, 2008

Matsumoto,M, Pocai,A, Rossetti,L, DePinho,RA, Accili,D: Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab 6:208-216, 2007

Lu,M, Wan,M, Leavens,KF, Chu,Q, Monks,BR, Fernandez,S, Ahima,RS, Ueki,K, Kahn,CR, Birnbaum,MJ: Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat Med 18:388-395, 2012

Valenti,L, Rametta,R, Dongiovanni,P, Maggioni,M, Fracanzani,AL, Zappa,M, Lattuada,E, Roviaro,G, Fargion,S: Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis. Diabetes 57:1355-1362, 2008

Cline,GW, Johnson,K, Regittnig,W, Perret,P, Tozzo,E, Xiao,L, Damico,C, Shulman,GI: Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes 51:2903-2910, 2002

MacAulay,K, Doble,BW, Patel,S, Hansotia,T, Sinclair,EM, Drucker,DJ, Nagy,A, Woodgett,JR: Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism. Cell Metab 6:329-337, 2007

Patel,S, Doble,BW, MacAulay,K, Sinclair,EM, Drucker,DJ, Woodgett,JR: Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action. Mol Cell Biol 28:6314-6328, 2008

Rao,R, Hao,CM, Redha,R, Wasserman,DH, McGuinness,OP, Breyer,MD: Glycogen synthase kinase 3 inhibition improves insulin-stimulated glucose metabolism but not hypertension in high-fat-fed C57BL/6J mice. Diabetologia 50:452-460, 2007

Torres,TP, Catlin,RL, Chan,R, Fujimoto,Y, Sasaki,N, Printz,RL, Newgard,CB, Shiota,M: Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats. Diabetes 58:78-86, 2009

Caro,JF, Triester,S, Patel,VK, Tapscott,EB, Frazier,NL, Dohm,GL: Liver glucokinase: decreased activity in patients with type II diabetes. Horm Metab Res 27:19-22, 1995

Belfiore,F, Romeo,F, Iannello,S, Salamone,C: The glucose-6-phosphatase/glucokinase ratio in the liver of obese-diabetic subjects. Biochem Med Metab Biol 41:77-80, 1989

Peter,A, Cegan,A, Wagner,S, Elcnerova,M, Konigsrainer,A, Konigsrainer,I, Haring,HU, Schleicher,ED, Stefan,N: Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans. Am J Physiol Endocrinol Metab 300:E321-E326, 2011

Schmid,AI, Szendroedi,J, Chmelik,M, Krssak,M, Moser,E, Roden,M: Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. Diabetes Care 34:448-453, 2011

Szendroedi,J, Chmelik,M, Schmid,AI, Nowotny,P, Brehm,A, Krssak,M, Moser,E, Roden,M: Abnormal hepatic energy homeostasis in type 2 diabetes. Hepatology 50:1079-1086, 2009

Stefan,N, Kantartzis,K, Machann,J, Schick,F, Thamer,C, Rittig,K, Balletshofer,B, Machicao,F, Fritsche,A, Haring,HU: Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168:1609-1616, 2008

Roden,M: Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2:335-348, 2006

Kotronen,A, Westerbacka,J, Bergholm,R, Pietilainen,KH, Yki-Jarvinen,H: Liver fat in the metabolic syndrome. J Clin Endocrinol Metab 92:3490-3497, 2007

Prikoszovich,T, Winzer,C, Schmid,AI, Szendroedi,J, Chmelik,M, Pacini,G, Krssak,M, Moser,E, Funahashi,T, Waldhausl,W, Kautzky-Willer,A, Roden,M: Body and liver fat mass rather than muscle mitochondrial function determine glucose metabolism in women with a history of gestational diabetes mellitus. Diabetes Care 34:430-436, 2011

Utzschneider,KM, Van de Lagemaat,A, Faulenbach,MV, Goedecke,JH, Carr,DB, Boyko,EJ, Fujimoto,WY, Kahn,SE: Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes. Obesity (Silver Spring) 18:1781-1787, 2010

Marchesini,G, Brizi,M, Bianchi,G, Tomassetti,S, Bugianesi,E, Lenzi,M, McCullough,AJ, Natale,S, Forlani,G, Melchionda,N: Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844-1850, 2001

Benhamed,F, Denechaud,PD, Lemoine,M, Robichon,C, Moldes,M, Bertrand-Michel,J, Ratziu,V, Serfaty,L, Housset,C, Capeau,J, Girard,J, Guillou,H, Postic,C: The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J Clin Invest 122:2176-2194, 2012

Westerbacka,J, Lammi,K, Hakkinen,AM, Rissanen,A, Salminen,I, Aro,A, Yki-Jarvinen,H: Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 90:2804-2809, 2005

van Herpen,NA, Schrauwen-Hinderling,VB, Schaart,G, Mensink,RP, Schrauwen,P: Three weeks on a high-fat diet increases intrahepatic lipid accumulation and decreases metabolic flexibility in healthy overweight men. J Clin Endocrinol Metab 96:E691-E695, 2011

Donnelly,KL, Smith,CI, Schwarzenberg,SJ, Jessurun,J, Boldt,MD, Parks,EJ: Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115:1343-1351, 2005

Schwarz,JM, Linfoot,P, Dare,D, Aghajanian,K: Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 77:43-50, 2003

Horton,JD, Goldstein,JL, Brown,MS: SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125-1131, 2002

Shimano,H, Shimomura,I, Hammer,RE, Herz,J, Goldstein,JL, Brown,MS, Horton,JD: Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J Clin Invest 100:2115-2124, 1997

Yahagi,N, Shimano,H, Hasty,AH, Matsuzaka,T, Ide,T, Yoshikawa,T, Amemiya-Kudo,M, Tomita,S, Okazaki,H, Tamura,Y, Iizuka,Y, Ohashi,K, Osuga,J, Harada,K, Gotoda,T, Nagai,R, Ishibashi,S, Yamada,N: Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J Biol Chem 277:19353-19357, 2002

Erion,DM, Shulman,GI: Diacylglycerol-mediated insulin resistance. Nat Med 16:400-402, 2010

Samuel,VT, Liu,ZX, Qu,X, Elder,BD, Bilz,S, Befroy,D, Romanelli,AJ, Shulman,GI: Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279:32345-32353, 2004

Savage,DB, Petersen,KF, Shulman,GI: Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 87:507-520, 2007

Crooke,ST: Progress in antisense technology. Annu Rev Med 55:61-95, 2004

Savage,DB, Choi,CS, Samuel,VT, Liu,ZX, Zhang,D, Wang,A, Zhang,XM, Cline,GW, Yu,XX, Geisler,JG, Bhanot,S, Monia,BP, Shulman,GI: Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J Clin Invest 116:817-824, 2006

Zhang,D, Liu,ZX, Choi,CS, Tian,L, Kibbey,R, Dong,J, Cline,GW, Wood,PA, Shulman,GI: Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc Natl Acad Sci U S A 104:17075-17080, 2007

Considine,RV, Nyce,MR, Allen,LE, Morales,LM, Triester,S, Serrano,J, Colberg,J, Lanza-Jacoby,S, Caro,JF: Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia. J Clin Invest 95:2938-2944, 1995

Jurczak,MJ, Lee,AH, Jornayvaz,FR, Lee,HY, Birkenfeld,AL, Guigni,BA, Kahn,M, Samuel,VT, Glimcher,LH, Shulman,GI: Dissociation of inositol-requiring enzyme (IRE1alpha)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-box-binding protein-1 (XBP1) knock-out mice. J Biol Chem 287:2558-2567, 2012

Bezy,O, Tran,TT, Pihlajamaki,J, Suzuki,R, Emanuelli,B, Winnay,J, Mori,MA, Haas,J, Biddinger,SB, Leitges,M, Goldfine,AB, Patti,ME, King,GL, Kahn,CR: PKCdelta regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans. J Clin Invest 121:2504-2517, 2011

Li,Z, Berk,M, McIntyre,TM, Gores,GJ, Feldstein,AE: The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology 47:1495-1503, 2008

Samuel,VT, Shulman,GI: Mechanisms for insulin resistance: common threads and missing links. Cell 148:852-871, 2012

Kammoun,HL, Chabanon,H, Hainault,I, Luquet,S, Magnan,C, Koike,T, Ferre,P, Foufelle,F: GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest 119:1201-1215, 2009

Achard,CS, Laybutt,DR: Lipid-induced endoplasmic reticulum stress in liver cells results in two distinct outcomes: adaptation with enhanced insulin signaling or insulin resistance. Endocrinology 153:2164-2177, 2012

Yoshida,H, Matsui,T, Yamamoto,A, Okada,T, Mori,K: XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107:881-891, 2001

Gastaldelli,A, Natali,A, Vettor,R, Corradini,SG: Insulin resistance, adipose depots and gut: interactions and pathological implications. Dig Liver Dis 42:310-319, 2010

Boden,G, Shulman,GI: Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32 Suppl 3:14-23, 2002

Ouchi,N, Parker,JL, Lugus,JJ, Walsh,K: Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11:85-97, 2011

Dandona,P, Aljada,A, Bandyopadhyay,A: Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25:4-7, 2004

Alexandraki,K, Piperi,C, Kalofoutis,C, Singh,J, Alaveras,A, Kalofoutis,A: Inflammatory process in type 2 diabetes: The role of cytokines. Ann N Y Acad Sci 1084:89-117, 2006

Weisberg,SP, McCann,D, Desai,M, Rosenbaum,M, Leibel,RL, Ferrante,AW, Jr.: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808, 2003

Xu,H, Barnes,GT, Yang,Q, Tan,G, Yang,D, Chou,CJ, Sole,J, Nichols,A, Ross,JS, Tartaglia,LA, Chen,H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-1830, 2003

Spranger,J, Kroke,A, Mohlig,M, Hoffmann,K, Bergmann,MM, Ristow,M, Boeing,H, Pfeiffer,AF: Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52:812-817, 2003

Shoelson,SE, Lee,J, Goldfine,AB: Inflammation and insulin resistance. J Clin Invest 116:1793-1801, 2006

Wellen,KE, Hotamisligil,GS: Inflammation, stress, and diabetes. J Clin Invest 115:1111-1119, 2005

Hundal,RS, Petersen,KF, Mayerson,AB, Randhawa,PS, Inzucchi,S, Shoelson,SE, Shulman,GI: Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 109:1321-1326, 2002

Yuan,M, Konstantopoulos,N, Lee,J, Hansen,L, Li,ZW, Karin,M, Shoelson,SE: Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293:1673-1677, 2001

Hanusch-Enserer,U, Brabant,G, Roden,M: Ghrelin concentrations in morbidly obese patients after adjustable gastric banding. N Engl J Med 348:2159-2160, 2003

Tziomalos,K, Dimitroula,HV, Katsiki,N, Savopoulos,C, Hatzitolios,AI: Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients. Mediators Inflamm 2010:364957, 2010

Summers,SA, Whiteman,EL, Birnbaum,MJ: Insulin signaling in the adipocyte. Int J Obes Relat Metab Disord 24 Suppl 4:S67-S70, 2000

Yu,X, Shen,N, Zhang,ML, Pan,FY, Wang,C, Jia,WP, Liu,C, Gao,Q, Gao,X, Xue,B, Li,CJ: Egr-1 decreases adipocyte insulin sensitivity by tilting PI3K/Akt and MAPK signal balance in mice. EMBO J 30:3754-3765, 2011

Guilherme,A, Virbasius,JV, Puri,V, Czech,MP: Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9:367-377, 2008

Shen,N, Yu,X, Pan,FY, Gao,X, Xue,B, Li,CJ: An early response transcription factor, Egr-1, enhances insulin resistance in type 2 diabetes with chronic hyperinsulinism. J Biol Chem 286:14508-14515, 2011

Fernandez-Veledo,S, Vila-Bedmar,R, Nieto-Vazquez,I, Lorenzo,M: c-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-alpha induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists. J Clin Endocrinol Metab 94:3583-3593, 2009

Arner,P: The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab 14:137-145, 2003

Gao,Z, Zhang,X, Zuberi,A, Hwang,D, Quon,MJ, Lefevre,M, Ye,J: Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol Endocrinol 18:2024-2034, 2004

Matsuzawa-Nagata,N, Takamura,T, Ando,H, Nakamura,S, Kurita,S, Misu,H, Ota,T, Yokoyama,M, Honda,M, Miyamoto,K, Kaneko,S: Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism 57:1071-1077, 2008

Ye,R, Jung,DY, Jun,JY, Li,J, Luo,S, Ko,HJ, Kim,JK, Lee,AS: Grp78 heterozygosity promotes adaptive unfolded protein response and attenuates diet-induced obesity and insulin resistance. Diabetes 59:6-16, 2010

Ye,R, Jung,DY, Jun,JY, Li,J, Luo,S, Ko,HJ, Kim,JK, Lee,AS: Grp78 heterozygosity promotes adaptive unfolded protein response and attenuates diet-induced obesity and insulin resistance. Diabetes 59:6-16, 2010

Ketterer,C, Tschritter,O, Preissl,H, Heni,M, Haring,HU, Fritsche,A: Insulin sensitivity of the human brain. Diabetes Res Clin Pract 93 Suppl 1:S47-S51, 2011

McEwen,BS, Reagan,LP: Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur J Pharmacol 490:13-24, 2004

Vidarsdottir,S, Smeets,PA, Eichelsheim,DL, van Osch,MJ, Viergever,MA, Romijn,JA, van der Grond,J, Pijl,H: Glucose ingestion fails to inhibit hypothalamic neuronal activity in patients with type 2 diabetes. Diabetes 56:2547-2550, 2007

Morton,GJ, Cummings,DE, Baskin,DG, Barsh,GS, Schwartz,MW: Central nervous system control of food intake and body weight. Nature 443:289-295, 2006

Smeets,PA, de,GC, Stafleu,A, van Osch,MJ, van der Grond,J: Functional MRI of human hypothalamic responses following glucose ingestion. Neuroimage 24:363-368, 2005

Schwartz,MW, Porte,D, Jr.: Diabetes, obesity, and the brain. Science 307:375-379, 2005

Tschritter,O, Preissl,H, Hennige,AM, Stumvoll,M, Porubska,K, Frost,R, Marx,H, Klosel,B, Lutzenberger,W, Birbaumer,N, Haring,HU, Fritsche,A: The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study. Proc Natl Acad Sci U S A 103:12103-12108, 2006

Hallschmid,M, Benedict,C, Schultes,B, Born,J, Kern,W: Obese men respond to cognitive but not to catabolic brain insulin signaling. Int J Obes (Lond) 32:275-282, 2008

Caro,JF, Kolaczynski,JW, Nyce,MR, Ohannesian,JP, Opentanova,I, Goldman,WH, Lynn,RB, Zhang,PL, Sinha,MK, Considine,RV: Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348:159-161, 1996

Hallschmid,M, Randeva,H, Tan,BK, Kern,W, Lehnert,H: Relationship between cerebrospinal fluid visfatin (PBEF/Nampt) levels and adiposity in humans. Diabetes 58:637-640, 2009

Bruning,JC, Gautam,D, Burks,DJ, Gillette,J, Schubert,M, Orban,PC, Klein,R, Krone,W, Muller-Wieland,D, Kahn,CR: Role of brain insulin receptor in control of body weight and reproduction. Science 289:2122-2125, 2000

Kodl,CT, Seaquist,ER: Cognitive dysfunction and diabetes mellitus. Endocr Rev 29:494-511, 2008

Anthony,K, Reed,LJ, Dunn,JT, Bingham,E, Hopkins,D, Marsden,PK, Amiel,SA: Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome? Diabetes 55:2986-2992, 2006

Yue,JT, Lam,TK: Lipid sensing and insulin resistance in the brain. Cell Metab 15:646-655, 2012

Levin,BE, Sherwin,RS: Peripheral glucose homeostasis: does brain insulin matter? J Clin Invest 121:3392-3395, 2011

Spanswick,D, Smith,MA, Mirshamsi,S, Routh,VH, Ashford,ML: Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci 3:757-758, 2000

Ramnanan,CJ, Saraswathi,V, Smith,MS, Donahue,EP, Farmer,B, Farmer,TD, Neal,D, Williams,PE, Lautz,M, Mari,A, Cherrington,AD, Edgerton,DS: Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogs. J Clin Invest 121:3713-3723, 2011

Talbot,K, Wang,HY, Kazi,H, Han,LY, Bakshi,KP, Stucky,A, Fuino,RL, Kawaguchi,KR, Samoyedny,AJ, Wilson,RS, Arvanitakis,Z, Schneider,JA, Wolf,BA, Bennett,DA, Trojanowski,JQ, Arnold,SE: Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122:1316-1338, 2012

Porzio,O, Federici,M, Hribal,ML, Lauro,D, Accili,D, Lauro,R, Borboni,P, Sesti,G: The Gly972-->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells. J Clin Invest 104:357-364, 1999

Hribal,ML, Federici,M, Porzio,O, Lauro,D, Borboni,P, Accili,D, Lauro,R, Sesti,G: The Gly-->Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells. J Clin Endocrinol Metab 85:2004-2013, 2000

Hallschmid,M, Benedict,C, Schultes,B, Fehm,HL, Born,J, Kern,W: Intranasal insulin reduces body fat in men but not in women. Diabetes 53:3024-3029, 2004

Heni,M, Kullmann,S, Ketterer,C, Guthoff,M, Linder,K, Wagner,R, Stingl,KT, Veit,R, Staiger,H, Haring,HU, Preissl,H, Fritsche,A: Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions. Diabetologia 55:1773-1782, 2012

Pagotto,U: Where does insulin resistance start? The brain. Diabetes Care 32 Suppl 2:S174-S177, 2009

Obici,S, Zhang,BB, Karkanias,G, Rossetti,L: Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8:1376-1382, 2002

Koch,L, Wunderlich,FT, Seibler,J, Konner,AC, Hampel,B, Irlenbusch,S, Brabant,G, Kahn,CR, Schwenk,F, Bruning,JC: Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest 118:2132-2147, 2008

Perrin,C, Knauf,C, Burcelin,R: Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis. Endocrinology 145:4025-4033, 2004

Scherer,T, O'Hare,J, Diggs-Andrews,K, Schweiger,M, Cheng,B, Lindtner,C, Zielinski,E, Vempati,P, Su,K, Dighe,S, Milsom,T, Puchowicz,M, Scheja,L, Zechner,R, Fisher,SJ, Previs,SF, Buettner,C: Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab 13:183-194, 2011

Petersen,KF, Oral,EA, Dufour,S, Befroy,D, Ariyan,C, Yu,C, Cline,GW, DePaoli,AM, Taylor,SI, Gorden,P, Shulman,GI: Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109:1345-1350, 2002

Clegg,DJ, Gotoh,K, Kemp,C, Wortman,MD, Benoit,SC, Brown,LM, D'Alessio,D, Tso,P, Seeley,RJ, Woods,SC: Consumption of a high-fat diet induces central insulin resistance independent of adiposity. Physiol Behav 103:10-16, 2011

Benoit,SC, Kemp,CJ, Elias,CF, Abplanalp,W, Herman,JP, Migrenne,S, Lefevre,AL, Cruciani-Guglielmacci,C, Magnan,C, Yu,F, Niswender,K, Irani,BG, Holland,WL, Clegg,DJ: Palmitic acid mediates hypothalamic insulin resistance by altering PKC-theta subcellular localization in rodents. J Clin Invest 119:2577-2589, 2009

Posey,KA, Clegg,DJ, Printz,RL, Byun,J, Morton,GJ, Vivekanandan-Giri,A, Pennathur,S, Baskin,DG, Heinecke,JW, Woods,SC, Schwartz,MW, Niswender,KD: Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am J Physiol Endocrinol Metab 296:E1003-E1012, 2009

de la Monte,SM, Tong,M, Nguyen,V, Setshedi,M, Longato,L, Wands,JR: Ceramide-mediated insulin resistance and impairment of cognitive-motor functions. J Alzheimers Dis 21:967-984, 2010

de la Monte,SM, Re,E, Longato,L, Tong,M: Dysfunctional Pro-Ceramide, ER Stress,and Insulin/IGF Signaling Networks with Progression of Alzheimer's Disease. J Alzheimers Dis 2012

Zhang,X, Zhang,G, Zhang,H, Karin,M, Bai,H, Cai,D: Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 135:61-73, 2008

Jaillard,T, Roger,M, Galinier,A, Guillou,P, Benani,A, Leloup,C, Casteilla,L, Penicaud,L, Lorsignol,A: Hypothalamic reactive oxygen species are required for insulin-induced food intake inhibition: an NADPH oxidase-dependent mechanism. Diabetes 58:1544-1549, 2009

Zhang,X, Dong,F, Ren,J, Driscoll,MJ, Culver,B: High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex. Exp Neurol 191:318-325, 2005

Hanley,AJ, Wagenknecht,LE, Norris,JM, Bryer-Ash,M, Chen,YI, Anderson,AM, Bergman,R, Haffner,SM: Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study. Diabetologia 52:2079-2086, 2009

Knowles,NG, Landchild,MA, Fujimoto,WY, Kahn,SE: Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes. Diabetes Care 25:292-297, 2002

Robertson,RP, Harmon,J, Tran,PO, Poitout,V: Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53 Suppl 1:S119-S124, 2004

Rhodes,CJ: Type 2 diabetes-a matter of beta-cell life and death? Science 307:380-384, 2005

Cnop,M, Igoillo-Esteve,M, Cunha,DA, Ladriere,L, Eizirik,DL: An update on lipotoxic endoplasmic reticulum stress in pancreatic beta-cells. Biochem Soc Trans 36:909-915, 2008

van Raalte,DH, van der Zijl,NJ, Diamant,M: Pancreatic steatosis in humans: cause or marker of lipotoxicity? Curr Opin Clin Nutr Metab Care 13:478-485, 2010

Cnop,M: Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes. Biochem Soc Trans 36:348-352, 2008

Smits,MM, van Geenen,EJ: The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol 8:169-177, 2011

Lee,Y, Lingvay,I, Szczepaniak,LS, Ravazzola,M, Orci,L, Unger,RH: Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int J Obes (Lond) 34:396-400, 2010

Lingvay,I, Esser,V, Legendre,JL, Price,AL, Wertz,KM, Adams-Huet,B, Zhang,S, Unger,RH, Szczepaniak,LS: Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 94:4070-4076, 2009

Heni,M, Machann,J, Staiger,H, Schwenzer,NF, Peter,A, Schick,F, Claussen,CD, Stefan,N, Haring,HU, Fritsche,A: Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev 26:200-205, 2010

Tushuizen,ME, Bunck,MC, Pouwels,PJ, Bontemps,S, van Waesberghe,JH, Schindhelm,RK, Mari,A, Heine,RJ, Diamant,M: Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 30:2916-2921, 2007

van der Zijl,NJ, Goossens,GH, Moors,CC, van Raalte,DH, Muskiet,MH, Pouwels,PJ, Blaak,EE, Diamant,M: Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on beta-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab 96:459-467, 2011

Giacca,A, Xiao,C, Oprescu,AI, Carpentier,AC, Lewis,GF: Lipid-induced pancreatic beta-cell dysfunction: focus on in vivo studies. Am J Physiol Endocrinol Metab 300:E255-E262, 2011

Kashyap,S, Belfort,R, Gastaldelli,A, Pratipanawatr,T, Berria,R, Pratipanawatr,W, Bajaj,M, Mandarino,L, DeFronzo,R, Cusi,K: A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52:2461-2474, 2003

Del Prato,S: Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies. Diabet Med 26:1185-1192, 2009

El-Assaad,W, Buteau,J, Peyot,ML, Nolan,C, Roduit,R, Hardy,S, Joly,E, Dbaibo,G, Rosenberg,L, Prentki,M: Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology 144:4154-4163, 2003

Jacqueminet,S, Briaud,I, Rouault,C, Reach,G, Poitout,V: Inhibition of insulin gene expression by long-term exposure of pancreatic beta cells to palmitate is dependent on the presence of a stimulatory glucose concentration. Metabolism 49:532-536, 2000

Pascoe,J, Hollern,D, Stamateris,R, Abbasi,M, Romano,LC, Zou,B, O'Donnell,CP, Garcia-Ocana,A, Alonso,LC: Free fatty acids block glucose-induced beta-cell proliferation in mice by inducing cell cycle inhibitors p16 and p18. Diabetes 61:632-641, 2012

Boden,G: Does inhibition of beta-cell proliferation by free fatty acid in mice explain the progressive failure of insulin secretion in type 2 diabetes? Diabetes 61:560-561, 2012

Schmitz-Peiffer,C, Laybutt,DR, Burchfield,JG, Gurisik,E, Narasimhan,S, Mitchell,CJ, Pedersen,DJ, Braun,U, Cooney,GJ, Leitges,M, Biden,TJ: Inhibition of PKCepsilon improves glucose-stimulated insulin secretion and reduces insulin clearance. Cell Metab 6:320-328, 2007

Zhang,X, Bao,Y, Ke,L, Yu,Y: Elevated circulating free fatty acids levels causing pancreatic islet cell dysfunction through oxidative stress. J Endocrinol Invest 33:388-394, 2010

Shimabukuro,M, Higa,M, Zhou,YT, Wang,MY, Newgard,CB, Unger,RH: Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 273:32487-32490, 1998

Kulkarni,RN: Receptors for insulin and insulin-like growth factor-1 and insulin receptor substrate-1 mediate pathways that regulate islet function. Biochem Soc Trans 30:317-322, 2002

Zhang,J, Gao,Z, Yin,J, Quon,MJ, Ye,J: S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2. J Biol Chem 283:35375-35382, 2008

Gual,P, Le Marchand-Brustel,Y, Tanti,JF: Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87:99-109, 2005





Add comment 





Home  Editorial Board  Search  Current Issue  Archive Issues  Announcements  Aims & Scope  About the Journal  How to Submit  Contact Us
Find out how to become a part of the HMJ  |   CLICK HERE >>
© Copyright 2012 - 2013 HMJ - HAMDAN Medical Journal. All Rights Reserved         Website Developed By Cedar Solutions INDIA